HCA Healthcare, Inc. (NYSE:HCA) Stake Decreased by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC lowered its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 151,076 shares of the company’s stock after selling 11,578 shares during the period. Wealth Enhancement Advisory Services LLC owned approximately 0.06% of HCA Healthcare worth $61,402,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. MFA Wealth Advisors LLC bought a new stake in HCA Healthcare during the second quarter worth approximately $27,000. Unique Wealth Strategies LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at $28,000. Bangor Savings Bank raised its position in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC boosted its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in shares of HCA Healthcare in the 2nd quarter worth approximately $33,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have issued reports on HCA. Truist Financial upped their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Leerink Partners upped their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Five research analysts have rated the stock with a hold rating, twelve have issued a buy rating and four have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $377.17.

HCA Healthcare Trading Down 8.9 %

NYSE:HCA opened at $363.55 on Friday. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The company has a market capitalization of $93.82 billion, a P/E ratio of 17.07, a P/E/G ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a 52 week low of $220.55 and a 52 week high of $417.14. The stock’s 50 day moving average price is $395.06 and its 200 day moving average price is $352.71.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.73%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is 12.39%.

Insiders Place Their Bets

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,345 shares of company stock valued at $5,747,945 over the last quarter. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.